| Record ID | marc_loc_updates/v37.i32.records.utf8:9980287:1628 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v37.i32.records.utf8:9980287:1628?format=raw |
LEADER: 01628cam a22003974a 4500
001 2009003127
003 DLC
005 20090808091254.0
008 090127s2009 flua b 001 0 eng
010 $a 2009003127
016 7 $a101494575$2DNLM
020 $a9781420070378 (hardcover : alk. paper)
020 $a1420070371 (hardcover : alk. paper)
035 $a(OCoLC)ocn166872492
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBTCTA$dBAKER$dYDXCP$dBWX$dDLC
042 $apcc
050 00 $aRM301.27$b.H47 2009
060 00 $a2009 E-635
060 10 $aQV 771$bH572d 2009
082 00 $a615/.19$222
100 1 $aHerson, Jay.
245 10 $aData and safety monitoring committees in clinical trials /$cJay Herson.
260 $aBoca Raton, FL :$bChapman & Hall/CRC,$cc2009.
300 $axviii, 173 p. :$bill. ;$c25 cm.
490 1 $aChapman & Hall/CRC biostatistics series ;$v30
504 $aIncludes bibliographical references (p. 155-166) and index.
505 0 $aIntroduction -- Organization of a safety monitoring program for a confirmatory trial -- Meetings -- Clinical issues -- Statistical issues -- Bias and pitfalls -- Data monitoring committee decisions -- Emerging issues.
650 0 $aDrugs$xTesting$xEvaluation.
650 0 $aDrugs$xTesting$xStatistical methods$xEvaluation.
650 12 $aClinical Trials Data Monitoring Committees$xorganization & administration.
650 12 $aClinical Trials as Topic$xstandards.
650 22 $aData Collection.
650 22 $aDrug Industry$xstandards.
650 22 $aResearch Design.
650 22 $aSafety Management.
830 0 $aChapman & Hall/CRC biostatistics series ;$v30.